Form 4 for MRNA Moderna
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-09 · accession 0001127602-22-025490 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-14 | 2022-11-09 | MRNA | Andres Juan | See remarks | M - OptEx | $17.19 | +2,435 | 14.0K | +21% | +$41.9K |
| DM | 2022-11-14 | 2022-11-09+ | MRNA | Andres Juan | See remarks | S - Sale+OE | $162.77 | -2,192 | 11.8K | -16% | -$356.8K |
| DM | 2022-11-14 | 2022-11-09 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -2,435 | 217.0K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-09 | M | A | 435 | $0.00 | 12,001 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-09 | M | A | 2,000 | $20.93 | 14,001 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-09 | S | D | 2,000 | $162.50 | 12,001 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-10 | S | D | 192 | $165.59 | 11,809 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2022-11-09 | M | D | 435 | $0.00 | 10,413 | D | $0.00 · — to — | 435 Common Stock | (F4) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-11-09 | M | D | 2,000 | $0.00 | 217,025 | D | $20.93 · — to 2029-03-08 | 2,000 Common Stock | (F5) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |